Xiidra can start improving dry eye symptoms in as little as two weeks, though it often takes up to 12 weeks (three months) for the full effects to develop. The timeline varies from person to person, and not everyone who uses Xiidra will experience relief.
What to Expect in the First Two Weeks
In clinical trials submitted to the FDA, some patients showed measurable symptom improvement by day 14. This early relief typically involves a reduction in the eye dryness and discomfort that brought you to your doctor in the first place. Two of the major clinical studies used for FDA approval demonstrated symptom improvement at this two-week mark, which makes it one of the earliest timepoints where you might notice a difference.
That said, two weeks of improvement doesn’t mean the medication has finished working. The changes at this stage are often modest, and many people won’t notice anything meaningful this early. If you’re two weeks in and feeling no different, that’s completely normal and not a reason to stop.
The 6-Week and 12-Week Milestones
The more significant improvements tend to show up between six and twelve weeks. Across four clinical studies, symptom relief was demonstrated at six weeks (day 42), and three studies showed continued improvement at twelve weeks (day 84). This progressive timeline reflects how Xiidra works: rather than simply lubricating the eye surface, it addresses the underlying inflammation driving your dry eye disease. That inflammatory process doesn’t shut off overnight.
At the 12-week mark, clinical data showed that about 50% of patients using Xiidra had measurable improvement in corneal surface health, compared to 42% of patients using a placebo. For more substantial improvement, 17% of Xiidra patients hit that threshold versus 10% on placebo. These numbers highlight something important: while Xiidra does outperform placebo, the margins aren’t dramatic, and a meaningful percentage of people won’t see the results they’re hoping for.
Twelve weeks is generally the point where your eye doctor can assess whether Xiidra is actually working for you. If there’s no noticeable improvement in either your symptoms or your eye exam findings by that point, it may be time to discuss alternatives.
How Xiidra Reduces Inflammation
Dry eye disease isn’t just about not producing enough tears. In many cases, inflammation on the eye’s surface creates a cycle where immune cells damage the tissue, which triggers more inflammation, which causes more damage. Xiidra works by blocking a specific interaction between immune cells and the proteins they latch onto when mounting an inflammatory response. By disrupting that connection, it reduces immune cell activity on the eye surface, slows the inflammatory cycle, and gives the tissue a chance to heal.
This mechanism explains why the medication takes weeks to reach full effectiveness. You’re not just adding moisture to the eye. You’re gradually calming an immune response that has been building over months or years.
How to Use It Correctly
Xiidra is applied as one drop in each eye, twice daily, roughly 12 hours apart. It comes in single-use containers, each holding enough solution for both eyes in one session. After using a container, throw it away, even if there’s liquid left inside. The extra liquid is built in as a buffer in case you miss getting the drop into your eye on the first attempt.
If you wear contact lenses, remove them before applying the drops and wait at least 15 minutes before putting them back in. Keep the tip of the container away from your eye and any other surfaces to avoid contamination. Store unused containers in their original foil pouch at room temperature (roughly 68°F to 77°F) and away from light.
Common Side Effects
The most frequently reported side effects in clinical trials affected 5% to 25% of patients. These include irritation at the application site, an unusual taste in your mouth (often described as metallic or bitter), and temporarily blurred vision. The taste issue is particularly common and happens because the drops can drain through the tear ducts into the back of the throat. It’s harmless but can be unpleasant. Some people find it fades over time as they get used to the medication.
How Xiidra Compares to Restasis
Restasis (cyclosporine) is the other major prescription eye drop for dry eye disease, and many people wonder which works faster. No head-to-head clinical trials have directly compared the two medications. Restasis is generally considered slower to take effect, with many doctors advising patients to use it for three to six months before judging its effectiveness. Xiidra’s two-week signal in clinical trials gives it a potential edge on speed, but individual responses to either drug vary widely.
The two medications also work through different biological pathways, which means that failing on one doesn’t necessarily predict failure on the other. If Xiidra hasn’t worked after a full 12-week trial, switching to Restasis (or vice versa) is a reasonable next step.
Setting Realistic Expectations
Consistency matters more than anything else with Xiidra. Skipping doses or using it sporadically undermines the gradual anti-inflammatory effect the drug relies on. Twice a day, every day, for at least 12 weeks gives you the best chance of seeing results.
It’s also worth knowing that Xiidra doesn’t work for everyone. The clinical trial data shows a real but modest advantage over placebo, meaning some of the improvement people experience would have happened regardless. If you reach the three-month mark with no change in symptoms and no improvement on your eye exam, the medication likely isn’t a good fit for you. But if you’re only a few weeks in and feeling impatient, the evidence suggests it’s worth sticking with it.